Axios: “The Food and Drug Administration has issued an emergency use authorization (EUA) for Moderna’s COVID-19 vaccine, one day after it was endorsed by a panel of independent experts. The authorization of a second coronavirus vaccine, coming exactly one week after the FDA cleared Pfizer-BioNTech’s vaccine for emergency use, marks another milestone in the country’s path to curbing the pandemic and increases access for millions of Americans. Moderna’s vaccine, which the FDA confirmed is safe and has a 94.1% efficacy rate, does not need to be stored at ultracold temperatures and comes in smaller batches, making it easier to distribute to rural areas than Pfizer’s vaccine.”